Morán-Mariños Cristian, Visconti-Lopez Fabriccio J, Espiche Carlos, Llanos-Tejada Felix, Villanueva-Villegas Renzo, Casanova-Mendoza Renato, Bernal-Turpo Capriny
Unidad de Investigación en Bibliometría, Vicerrectorado de Investigación, Universidad San Ignacio de Loyola, Lima, Peru.
Unidad Especializada en Tuberculosis, Servicio de Neumología, Hospital Nacional Dos de Mayo, Lima, Peru.
Heliyon. 2024 Jul 18;10(15):e34828. doi: 10.1016/j.heliyon.2024.e34828. eCollection 2024 Aug 15.
Tuberculosis (TB) poses a significant global public health challenge, particularly in developing countries. Over the years, scientific research has played a pivotal role in addressing this disease. In this study, we aimed to analyze and outline the trends in scientific output on TB and identify research priorities in Latin America (LA) from 1990 to 2021. Scientific production was analyzed, and the number of publications, financing sources, and journal characteristics were evaluated. Collaboration networks and keywords were visualized using mapping analysis with VOSviewer software. Research themes were prioritized by country based on co-occurrence frequency. In total, 4399 documents were identified, a significant trend was evident in the number of publications per year (R = 0.981), and research substantially contributed to the reduction of TB-related mortality (R = -0.876). Most publications were original articles (83.8 %). The had the highest publication and citation rates per document. International collaboration was predominantly with the United States, France, and Canada. Brazil, Argentina, and Mexico had the highest number of publications and external collaborations. In LA, interest in researching studies related to treatment and diagnosis (32.5 %) was notably high, followed by epidemiology and screening (26.9 %). Among the 20 countries in LA, research priorities varied, with the highest emphasis on HIV/AIDS (14/20), epidemiology (9/20), anti-TB agents (6/20), and mortality (5/20). TB resistance was only considered a research priority in Brazil, Peru, and Haiti. Therefore, LA experienced significant growth in its scientific output, playing a crucial role in TB control. Strategic adaptation to the region's specific challenges was observed, particularly in HIV/AIDS coinfection, epidemiological studies, and drug resistance. This progress was achieved by outstanding international scientific collaboration. This holistic approach emphasizes the importance of research in the fight against TB in LA.
结核病对全球公共卫生构成了重大挑战,在发展中国家尤为如此。多年来,科学研究在应对这一疾病方面发挥了关键作用。在本研究中,我们旨在分析和概述1990年至2021年期间拉丁美洲关于结核病的科学产出趋势,并确定研究重点。我们分析了科学产出,评估了出版物数量、资金来源和期刊特征。使用VOSviewer软件通过映射分析可视化了合作网络和关键词。根据共现频率按国家对研究主题进行了优先排序。总共确定了4399份文献,每年的出版物数量呈现出显著趋势(R = 0.981),研究对降低结核病相关死亡率做出了重大贡献(R = -0.876)。大多数出版物为原创文章(83.8%)。[此处原文缺失相关信息]每份文献的发表率和被引率最高。国际合作主要是与美国、法国和加拿大。巴西、阿根廷和墨西哥的出版物数量和外部合作最多。在拉丁美洲,对治疗和诊断相关研究的兴趣(32.5%)显著较高,其次是流行病学和筛查(26.9%)。在拉丁美洲的20个国家中,研究重点各不相同,对艾滋病毒/艾滋病(14/20)、流行病学(9/20)、抗结核药物(6/20)和死亡率(5/20)的重视程度最高。结核病耐药性仅在巴西、秘鲁和海地被视为研究重点。因此,拉丁美洲的科学产出显著增长,在结核病控制中发挥了关键作用。观察到对该地区特定挑战的战略调整,特别是在艾滋病毒/艾滋病合并感染、流行病学研究和耐药性方面。这一进展是通过出色的国际科学合作实现的。这种整体方法强调了研究在拉丁美洲抗击结核病中的重要性。